Kilitch Drugs

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "370.50",
    "chg": 4.45,
    "chgp": "1.22%",
    "dir": 1,
    "prev_price": "366.05",
    "mcapval": "660.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE729D01010",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": "23.64 k",
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs (India) Ltd Sees Mixed Technical Signals Amid Sideways Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-sees-mixed-technical-signals-amid-sideways-momentum-shift-3829524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_technicaldot_3829524.png",
        "date": "2026-02-10 08:00:44",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bearish trend to a sideways pattern. Despite a day gain of 2.82% to close at ₹366.00, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments, placing them in the context of the company’s broader market performance and sector dynamics."
      },
      {
        "title": "Kilitch Drugs Surges 14.45% in a Week: Valuation Pressure and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-surges-1445-in-a-week-valuation-pressure-and-mixed-technical-signals-3827463",
        "imagepath": "",
        "date": "2026-02-08 14:00:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens strong at Rs.323.85, up 4.13%</p>\n                    <p><strong>5 Feb:</strong> Mixed technical signals amid price momentum shift</p>\n                    <p><strong>6 Feb:</strong> Valuation shifts signal growing price pressure</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.355.95, +14.45% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.311.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.355.95</div><div class=\"stat..."
      },
      {
        "title": "Kilitch Drugs Valuation Shifts Signal Growing Price Pressure Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-signal-growing-price-pressure-amid-strong-returns-3823487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_valuationdot_3823487.png",
        "date": "2026-02-06 08:00:17",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating, raising questions about its current price attractiveness amid strong recent returns and sector dynamics."
      },
      {
        "title": "When is the next results date for Kilitch Drugs (India) Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-kilitch-drugs-india-ltd-3823067",
        "imagepath": "",
        "date": "2026-02-05 23:16:46",
        "description": "The next results date for Kilitch Drugs (India) Ltd is scheduled for 11 February 2026...."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3821508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_technicaldot_3821508.png",
        "date": "2026-02-05 08:00:22",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with recent data revealing a transition from bearish to mildly bearish trends. Despite a robust day gain of 5.42%, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the evolving technical landscape, examining key metrics such as MACD, RSI, moving averages, and other momentum oscillators to provide investors with a comprehensive view of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Kilitch Drugs (India) Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kilitch-drugs-india-ltd-fallingrising-3821369",
        "imagepath": "",
        "date": "2026-02-05 00:49:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Short-Term Momentum and Market Outperformance</strong></p>\n<p>The stock has demonstrated impressive momentum over the past week, delivering a 10.63% return compared to the Sensex’s modest 1.79% gain during the same period. This outperformance is particularly striking given the broader market’s subdued performance over the month, where Kilitch Drugs posted a marginal decline of 0.79%, outperforming the Sensex’s 2.27% fall. Year-to-date, the stock has managed a positive return of 0.56%, while the benchmark index remains down by 1.65%.</p>\n<p>Such relative strength indicates growing investor confidence in Kilitch Drugs amid a challenging market environment. The stock’s ability to outperform its sector by 5.61% on the day further underscores its appeal to market participants seeking resil..."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-sell-3820415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_mojoScore_3820415.png",
        "date": "2026-02-04 10:10:04",
        "description": "Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-sell-3803095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KilitchDrugsInd_mojoScore_3803095.png",
        "date": "2026-01-24 10:10:03",
        "description": "Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-bearish-momentum-amid-technical-downturn-3782472",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KilitchDrugsInd_technicaldot_3782472.png",
        "date": "2026-01-06 08:04:14",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite recent short-term gains, the stock’s technical parameters have deteriorated, prompting a downgrade in its Mojo Grade to Sell as of 1 September 2025. This article analyses the evolving price momentum, technical indicator signals, and broader market context to provide a comprehensive view of the stock’s outlook."
      }
    ],
    "total": 278,
    "sid": "189669",
    "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Considering And Approval Unaudited Quarterly Financial Results For The Quarter Ended 31St December 2025 Bonus Issue Increase Authorised Capital Convene EGM Finalise Record Date",
      "datetime": "04-Feb-2026",
      "details": "Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve unaudited quarterly financial results for the quarter ended 31st December 2025 Bonus Issue Increase Authorised Capital Convene EGM finalise record date",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "15-Jan-2026",
      "details": "We are submitting herewith the certificate under regulation74(5) received from our RTA",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Dec-2025",
      "details": "Trading window will be closed with effect from 1st January 2026 till expiry of 48 hours from the declaration of unaudited financial results of the company for the quarter ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Feb 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs (India) Ltd Sees Mixed Technical Signals Amid Sideways Momentum Shift

2026-02-10 08:00:44

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bearish trend to a sideways pattern. Despite a day gain of 2.82% to close at ₹366.00, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments, placing them in the context of the company’s broader market performance and sector dynamics.

Read full news article

Kilitch Drugs Surges 14.45% in a Week: Valuation Pressure and Mixed Technical Signals

2026-02-08 14:00:15

Key Events This Week

2 Feb: Stock opens strong at Rs.323.85, up 4.13%

5 Feb: Mixed technical signals amid price momentum shift

6 Feb: Valuation shifts signal growing price pressure

6 Feb: Week closes at Rs.355.95, +14.45% for the week

Week Open

Rs.311.00

Week Close

Rs.355.95

Read full news article

Kilitch Drugs Valuation Shifts Signal Growing Price Pressure Amid Strong Returns

2026-02-06 08:00:17

Kilitch Drugs (India) Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating, raising questions about its current price attractiveness amid strong recent returns and sector dynamics.

Read full news article

When is the next results date for Kilitch Drugs (India) Ltd?

2026-02-05 23:16:46

The next results date for Kilitch Drugs (India) Ltd is scheduled for 11 February 2026....

Read full news article

Kilitch Drugs (India) Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-02-05 08:00:22

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with recent data revealing a transition from bearish to mildly bearish trends. Despite a robust day gain of 5.42%, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the evolving technical landscape, examining key metrics such as MACD, RSI, moving averages, and other momentum oscillators to provide investors with a comprehensive view of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Kilitch Drugs (India) Ltd falling/rising?

2026-02-05 00:49:55

Strong Short-Term Momentum and Market Outperformance

The stock has demonstrated impressive momentum over the past week, delivering a 10.63% return compared to the Sensex’s modest 1.79% gain during the same period. This outperformance is particularly striking given the broader market’s subdued performance over the month, where Kilitch Drugs posted a marginal decline of 0.79%, outperforming the Sensex’s 2.27% fall. Year-to-date, the stock has managed a positive return of 0.56%, while the benchmark index remains down by 1.65%.

Such relative strength indicates growing investor confidence in Kilitch Drugs amid a challenging market environment. The stock’s ability to outperform its sector by 5.61% on the day further underscores its appeal to market participants seeking resil...

Read full news article

Kilitch Drugs (India) Ltd is Rated Sell

2026-02-04 10:10:04

Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Kilitch Drugs (India) Ltd is Rated Sell

2026-01-24 10:10:03

Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn

2026-01-06 08:04:14

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite recent short-term gains, the stock’s technical parameters have deteriorated, prompting a downgrade in its Mojo Grade to Sell as of 1 September 2025. This article analyses the evolving price momentum, technical indicator signals, and broader market context to provide a comprehensive view of the stock’s outlook.

Read full news article

View All News